Our first annual symposium, held on the 7th September 2020 via Zoom, celebrated the breadth of fantastic cancer research going on across Norwich.
Background
The aims of the symposium were to highlight the wealth of quality cancer research going on at the Norwich Research Park and drive knowledge exchange so that new collaborations can be formed and new projects pursued. Participants were able to:
- Find out about the breadth of cancer research that occurs at the Norwich Research Park
- Gain insight into the real clinical problems faced in cancer care at the Norfolk and Norwich University Hospital
- Learn about new developments in cancer research covering the entire research spectrum
- Get ideas on forming new collaborations with researchers from across the Norwich Research Park
- Share their research with a friendly and engaged audience
Despite Covid-19 driving the event online, 120 delegates were able to hear a comprehensive range of 38 talks and lightening talks and participate in 2 poster sessions as well as numerous discussions and Q&A sessions.
The Symposium booklet can be found here: HYPERLINK (booklet attached) and its contents include: Welcome, Detailed Agenda, Abstracts, Poster Sessions, Details of the NCRN Virtual Seminar Series and List of Delegates.
The brief agenda
| Morning 09:00 to 09:10 | Welcome and Introduction to NCRN – Maria O’Connell |
| 09:10 to 10:05 |
Session 1 – GI and Hepatology Chair: Mark Williams |
| 10:05 to 10:15 | Break |
| 10:15 to 10:50 |
Session 2 – Skin Chair: Jelena Gavrolovic |
| 10:50 to 11:00 | Break |
| 11:00 to 11:40 |
Session 3 – Cross-cutting domain, Lung and Brain Chair: Dan Brewer |
| 11:40 to 11:50 | Break |
| 11:50 to 12:30 |
Session 4 – Cancer chemistry and drug discovery Chair: Andrew Beekman |
| 12:30 to 13:30 | Lunch/Poster Session 1 |
| 13:30 to 14:10 |
Session 5 – Prevention and Epidemiology Chair: Anne-Marie Minihane |
| 14:10 to 14:20 | Break |
| 14:20 to 15:05 |
Session 6 – Urology Chair: Rob Mills |
| 15:05 to 15:15 | Break |
| 15:15 to 15:50 |
Session 7 – Haematology Chair: Stuart Rushworth |
| 15:50 to 16:00 | Break |
| 16:00 to 16:40 |
Session 8 – Breast Chair: Dylan Edwards |
| 16:40 to 17:20 | Poster Session 2 |
| 17:20 to 17:30 | Closing remarks and prize announcements |
Links to Session Recordings (password: NCRN2020!)
Link to Recording 1:
Link to Recording 2:
Link to Recording 3:
Link to Recording 4:
Link to Recording 5:
Link to Recording 6:
Link to Recording 7:
Link to Recording 8:
Symposium Feedback
“There has been a series of fascinating talks today.”
Dr Melanie Pascale, Director of Charitable Operations, BigC
“Clinicians and researchers sharing their work and knowledge in all things cancer related.”
RSC East Anglia
“We are privileged to hear from clinicians as part of the NCRN Symposium, good to hear we are the single largest site for colorectal! These connections with clinicians and researchers is what is so impressive about Norwich.”
Dr Rianne Lord, Lecturer in Inorganic Chemistry, UEA
“Thanks for a great conference! I particularly enjoyed the clinician overviews – it’s rare to hear these kind of talks in one day. I learned a lot.”
Dr Jelena Gavrilovic, Cell Biologist/Norwich Skin Platform, UEA
“Many thanks to yourself and all the other organizers. I felt the day went very well without any hitches and the breadth and depth of cancer research across the NRP is simply amazing! Clearly we’re not very good at knowing what the rest of us are doing and events like this are critical for the future.”
Prof A. Ganesan, Chemical Biology, UEA
“It was a great event and I clocked 70+ participants in the Breast session – I didn’t check participants in the others that I dropped into, but I think the format worked really well. I would have liked to have seen some of the sessions with really rapid talks but didn’t get to any of them. All in all – a really great event!”
Prof Dylan Edwards, ProVC Faculty of Medicine and Health Sciences, UEA
For further information about the symposium or the Norwich Cancer Research Network contact Dr Dan Brewer (D.Brewer@uea.ac.uk) or Dr Karen Smith (Karen.L.Smith@uea.ac.uk)
More Case Studies
New nanoparticle cancer therapy takes a step closer to clinical trials
A tumour-promoting protein, (SK1), was identified in prostate and breast cancer cells which reduces the effectiveness of chemotherapy.
Read more >>
Improving Prostate Cancer Diagnosis
Prostate cancer has now overtaken breast cancer for the greatest annual number of fatalities caused by cancer and continues to…